[Press Release] VIPC’s Virginia Venture Partners Invests in ThinkGenetic to More Effectively Identify Rare Disease
Virginia Venture Partners, the equity investment program of Virginia Innovation Partnership Corporation (VIPC), today announced an investment in ThinkGenetic.
ThinkGenetic to Present Research Findings at 2023 NSGC Annual Meeting
ThinkGenetic announces its participation at the 2023 National Society of Genetic Counselors (NSGC) Annual Meeting in Chicago, IL this October through the presentation of two poster sessions.
What can ThinkGenetic do with ChatGPT?
ChatGPT has tremendous buzz! Learn how ThinkGenetic evaluates new tech for flagging rare patients.
ThinkGenetic to Attend ACMG/SIMD Joint Meeting
ThinkGenetic announces its participation at the 2023 ACMG Annual Clinical Genetics Meeting which is being held in conjunction with the Society for Inherited Metabolic Disorders Meeting for the first time in Salt Lake City, Utah, this March.
ThinkGenetic Announces Participation at 19th Annual WORLDSymposium™ 2023
ThinkGenetic announces that Chief Genetic Officer, Dawn Laney, MS, CGC, CCRC, will be participating in a 19th Annual WORLDSymposium™ Satellite Symposia entitled “Understanding Phenotypic Variability in Lysosomal Diseases – Gaining a Foothold in Precision Medicine” sponsored by Takeda Pharmaceutical Company Limited.
[Press Release] ThinkGenetic Announces Cian Robinson as Chief Revenue Officer to Focus on Growth and Partnership Opportunities
ThinkGenetic, Inc. (thinkgenetic.com) today announces the onboarding of entrepreneurial leader, Cian Robinson, MS, EdD-ABD as Chief Revenue Officer. Mr. Robinson is responsible for collaborating with potential ThinkGenetic clients to uncover opportunities for growth and partnership within ThinkGenetic.
